Report Detail
Global Submucosal Injection Agent Market Growth 2022-2028
- RnM4474850 |
- 01 August, 2022 |
- Global |
- 97 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
The global market for Submucosal Injection Agent is estimated to increase from $ 93 million in 2021 to reach $ 159.2 million by 2028, exhibiting a CAGR of 7.9% during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Submucosal Injection Agent market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Submucosal Injection Agent market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Submucosal Injection Agent market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Submucosal Injection Agent market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Submucosal Injection Agent players cover Seikagaku, Ovesco Endoscopy, GI Supply, Cosmo Pharmaceuticals and Boston Scientific, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Submucosal Injection Agent market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Submucosal Injection Agent market, with both quantitative and qualitative data, to help readers understand how the Submucosal Injection Agent market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Submucosal Injection Agent market and forecasts the market size by Type (Syringe Type and Ampoule Type,), by Application (Hospitals, Ambulatory Surgical Centers and Specialty Clinics,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Syringe Type
Ampoule Type
Segmentation by application
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Seikagaku
Ovesco Endoscopy
GI Supply
Cosmo Pharmaceuticals
Boston Scientific
The Standard
Micro-Tech Endoscopy
EndoClot Plus
Chapter Introduction
Chapter 1: Scope of Submucosal Injection Agent, Research Methodology, etc.
Chapter 2: Executive Summary, global Submucosal Injection Agent market size (sales and revenue) and CAGR, Submucosal Injection Agent market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Submucosal Injection Agent sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Submucosal Injection Agent sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Submucosal Injection Agent market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Seikagaku, Ovesco Endoscopy, GI Supply, Cosmo Pharmaceuticals, Boston Scientific, The Standard, Micro-Tech Endoscopy and EndoClot Plus, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Submucosal Injection Agent Annual Sales 2017-2028
- 2.1.2 World Current & Future Analysis for Submucosal Injection Agent by Geographic Region, 2017, 2022 & 2028
- 2.1.3 World Current & Future Analysis for Submucosal Injection Agent by Country/Region, 2017, 2022 & 2028
- 2.2 Submucosal Injection Agent Segment by Type
- 2.2.1 Syringe Type
- 2.2.2 Ampoule Type
- 2.3 Submucosal Injection Agent Sales by Type
- 2.3.1 Global Submucosal Injection Agent Sales Market Share by Type (2017-2022)
- 2.3.2 Global Submucosal Injection Agent Revenue and Market Share by Type (2017-2022)
- 2.3.3 Global Submucosal Injection Agent Sale Price by Type (2017-2022)
- 2.4 Submucosal Injection Agent Segment by Application
- 2.4.1 Hospitals
- 2.4.2 Ambulatory Surgical Centers
- 2.4.3 Specialty Clinics
- 2.5 Submucosal Injection Agent Sales by Application
- 2.5.1 Global Submucosal Injection Agent Sale Market Share by Application (2017-2022)
- 2.5.2 Global Submucosal Injection Agent Revenue and Market Share by Application (2017-2022)
- 2.5.3 Global Submucosal Injection Agent Sale Price by Application (2017-2022)
3 Global Submucosal Injection Agent by Company
- 3.1 Global Submucosal Injection Agent Breakdown Data by Company
- 3.1.1 Global Submucosal Injection Agent Annual Sales by Company (2020-2022)
- 3.1.2 Global Submucosal Injection Agent Sales Market Share by Company (2020-2022)
- 3.2 Global Submucosal Injection Agent Annual Revenue by Company (2020-2022)
- 3.2.1 Global Submucosal Injection Agent Revenue by Company (2020-2022)
- 3.2.2 Global Submucosal Injection Agent Revenue Market Share by Company (2020-2022)
- 3.3 Global Submucosal Injection Agent Sale Price by Company
- 3.4 Key Manufacturers Submucosal Injection Agent Producing Area Distribution, Sales Area, Product Type
- 3.4.1 Key Manufacturers Submucosal Injection Agent Product Location Distribution
- 3.4.2 Players Submucosal Injection Agent Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Submucosal Injection Agent by Geographic Region
- 4.1 World Historic Submucosal Injection Agent Market Size by Geographic Region (2017-2022)
- 4.1.1 Global Submucosal Injection Agent Annual Sales by Geographic Region (2017-2022)
- 4.1.2 Global Submucosal Injection Agent Annual Revenue by Geographic Region
- 4.2 World Historic Submucosal Injection Agent Market Size by Country/Region (2017-2022)
- 4.2.1 Global Submucosal Injection Agent Annual Sales by Country/Region (2017-2022)
- 4.2.2 Global Submucosal Injection Agent Annual Revenue by Country/Region
- 4.3 Americas Submucosal Injection Agent Sales Growth
- 4.4 APAC Submucosal Injection Agent Sales Growth
- 4.5 Europe Submucosal Injection Agent Sales Growth
- 4.6 Middle East & Africa Submucosal Injection Agent Sales Growth
5 Americas
- 5.1 Americas Submucosal Injection Agent Sales by Country
- 5.1.1 Americas Submucosal Injection Agent Sales by Country (2017-2022)
- 5.1.2 Americas Submucosal Injection Agent Revenue by Country (2017-2022)
- 5.2 Americas Submucosal Injection Agent Sales by Type
- 5.3 Americas Submucosal Injection Agent Sales by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
6 APAC
- 6.1 APAC Submucosal Injection Agent Sales by Region
- 6.1.1 APAC Submucosal Injection Agent Sales by Region (2017-2022)
- 6.1.2 APAC Submucosal Injection Agent Revenue by Region (2017-2022)
- 6.2 APAC Submucosal Injection Agent Sales by Type
- 6.3 APAC Submucosal Injection Agent Sales by Application
- 6.4 China
- 6.5 Japan
- 6.6 South Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 China Taiwan
7 Europe
- 7.1 Europe Submucosal Injection Agent by Country
- 7.1.1 Europe Submucosal Injection Agent Sales by Country (2017-2022)
- 7.1.2 Europe Submucosal Injection Agent Revenue by Country (2017-2022)
- 7.2 Europe Submucosal Injection Agent Sales by Type
- 7.3 Europe Submucosal Injection Agent Sales by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
8 Middle East & Africa
- 8.1 Middle East & Africa Submucosal Injection Agent by Country
- 8.1.1 Middle East & Africa Submucosal Injection Agent Sales by Country (2017-2022)
- 8.1.2 Middle East & Africa Submucosal Injection Agent Revenue by Country (2017-2022)
- 8.2 Middle East & Africa Submucosal Injection Agent Sales by Type
- 8.3 Middle East & Africa Submucosal Injection Agent Sales by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
- 10.1 Raw Material and Suppliers
- 10.2 Manufacturing Cost Structure Analysis of Submucosal Injection Agent
- 10.3 Manufacturing Process Analysis of Submucosal Injection Agent
- 10.4 Industry Chain Structure of Submucosal Injection Agent
11 Marketing, Distributors and Customer
- 11.1 Sales Channel
- 11.1.1 Direct Channels
- 11.1.2 Indirect Channels
- 11.2 Submucosal Injection Agent Distributors
- 11.3 Submucosal Injection Agent Customer
12 World Forecast Review for Submucosal Injection Agent by Geographic Region
- 12.1 Global Submucosal Injection Agent Market Size Forecast by Region
- 12.1.1 Global Submucosal Injection Agent Forecast by Region (2023-2028)
- 12.1.2 Global Submucosal Injection Agent Annual Revenue Forecast by Region (2023-2028)
- 12.2 Americas Forecast by Country
- 12.3 APAC Forecast by Region
- 12.4 Europe Forecast by Country
- 12.5 Middle East & Africa Forecast by Country
- 12.6 Global Submucosal Injection Agent Forecast by Type
- 12.7 Global Submucosal Injection Agent Forecast by Application
13 Key Players Analysis
- 13.1 Seikagaku
- 13.1.1 Seikagaku Company Information
- 13.1.2 Seikagaku Submucosal Injection Agent Product Offered
- 13.1.3 Seikagaku Submucosal Injection Agent Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.1.4 Seikagaku Main Business Overview
- 13.1.5 Seikagaku Latest Developments
- 13.2 Ovesco Endoscopy
- 13.2.1 Ovesco Endoscopy Company Information
- 13.2.2 Ovesco Endoscopy Submucosal Injection Agent Product Offered
- 13.2.3 Ovesco Endoscopy Submucosal Injection Agent Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.2.4 Ovesco Endoscopy Main Business Overview
- 13.2.5 Ovesco Endoscopy Latest Developments
- 13.3 GI Supply
- 13.3.1 GI Supply Company Information
- 13.3.2 GI Supply Submucosal Injection Agent Product Offered
- 13.3.3 GI Supply Submucosal Injection Agent Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.3.4 GI Supply Main Business Overview
- 13.3.5 GI Supply Latest Developments
- 13.4 Cosmo Pharmaceuticals
- 13.4.1 Cosmo Pharmaceuticals Company Information
- 13.4.2 Cosmo Pharmaceuticals Submucosal Injection Agent Product Offered
- 13.4.3 Cosmo Pharmaceuticals Submucosal Injection Agent Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.4.4 Cosmo Pharmaceuticals Main Business Overview
- 13.4.5 Cosmo Pharmaceuticals Latest Developments
- 13.5 Boston Scientific
- 13.5.1 Boston Scientific Company Information
- 13.5.2 Boston Scientific Submucosal Injection Agent Product Offered
- 13.5.3 Boston Scientific Submucosal Injection Agent Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.5.4 Boston Scientific Main Business Overview
- 13.5.5 Boston Scientific Latest Developments
- 13.6 The Standard
- 13.6.1 The Standard Company Information
- 13.6.2 The Standard Submucosal Injection Agent Product Offered
- 13.6.3 The Standard Submucosal Injection Agent Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.6.4 The Standard Main Business Overview
- 13.6.5 The Standard Latest Developments
- 13.7 Micro-Tech Endoscopy
- 13.7.1 Micro-Tech Endoscopy Company Information
- 13.7.2 Micro-Tech Endoscopy Submucosal Injection Agent Product Offered
- 13.7.3 Micro-Tech Endoscopy Submucosal Injection Agent Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.7.4 Micro-Tech Endoscopy Main Business Overview
- 13.7.5 Micro-Tech Endoscopy Latest Developments
- 13.8 EndoClot Plus
- 13.8.1 EndoClot Plus Company Information
- 13.8.2 EndoClot Plus Submucosal Injection Agent Product Offered
- 13.8.3 EndoClot Plus Submucosal Injection Agent Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.8.4 EndoClot Plus Main Business Overview
- 13.8.5 EndoClot Plus Latest Developments
14 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Submucosal Injection Agent. Industry analysis & Market Report on Submucosal Injection Agent is a syndicated market report, published as Global Submucosal Injection Agent Market Growth 2022-2028. It is complete Research Study and Industry Analysis of Submucosal Injection Agent market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
